PHILADELPHIA, PA / ACCESSWIRE / Olfactory Biosciences Corp (OLFC) is pleased to launchtoday a new special and timely product, NOXO Sensory Balm(TM). http://noxoinfo.com/sensory
Clinical, researchers found that children affected with Sensory perception issues have quantifiable differences in brain structure, confirming a biological basis for the problems that sets it apart from neurodevelopmental disorders such as ADHD and autism.
More than 1 child in every classroom are typically misdiagnosed with ADHD or autism, or they are not diagnosed at all...Instead an assumption is made that the child has ‘bad’ behavior. Sadly, parents are accused of not disciplining their children appropriately or not providing enough structure for their children.Whether you are biting into a hamburger, riding a bicycle, or reading a book, your successful completion of the activity requires processing sensations or "sensory integration." When there are odors or environmentally related issues, the sensory signals don’t get organized into appropriate responses.
Pioneering occupational therapist and neuroscientist A. Jean Ayres, PhD, likened the problems to a "traffic jam" that prevents certain parts of the brain from receiving the information needed to interpret sensory information correctly.
New NOXO Sensory Balm(TM), when applied topically, under the nose, an individual with sensory issues can find relief from environmental odors and integration issues that have the potential to trigger coping responses.
The NOXO molecules transports their "messages" directly to the brain's limbic system which may change behavior by reducing the intensity or the way the brain receives messages from the senses.
Whether you are biting into a hamburger, riding a bicycle, or reading a book, your successful completion of the activity requires processing sensations or "sensory integration." When there are offensive odors or environmentally related issues, the sensory signals don’t get organized into appropriate responses.
Pioneering occupational therapist and neuroscientist A. Jean Ayres, PhD, likened the problems to a "traffic jam" that prevents certain parts of the brain from receiving the information needed to interpret sensoryinformation correctly.
NOXO Sensory Balm(TM) was invented by Director of Research, Dr. V Ruth Pinney using both the company’s proprietary science and that of the NOBEL Prize in Medicine Winners of 2004 Richard Axel and Linda Buck. The company has been successful in targeting olfactory receptors with the company’s proprietary balm’s scents resulting in the desired modifications.
Ingredients: A special proprietary formulation of Phytonutrients and Phytochemicals taken from plants, flowers, roots and seeds. All ingredients are in a high quality White Petrolatum that complies with White Petrolatum USP requirements and FDA requirements ( 21 CFR 172.880) The specific chemical identities of the ingredients in this mixture are considered by us to be trade secrets and are withheld in accordance with the provisions of the 1910.1200 of the Code of Federal RegulationsFuther Information and purchasing can be found at http://noxoinfo.com/sensory
About Olfactory Biosciences CorpOlfactory Biosciences Corp.'s NOXO division is focused to develop a variety of products targeting Olfactory Receptors in the nose for the desired effect. These alternative medicine wellness products can modify behavior or provide relief to common behavior challenges such as anxiety or weight control, as examples. (http://www.noxoinfo.com/investor)
FORWARD-LOOKING STATEMENTS"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Richard Stevenson, President
Olfactory Biosciences Corp.333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096,
USA
Phone: 484-278-1626
Corporate Website: http://www.noxoinfo.com/